Viewing Study NCT03409250


Ignite Creation Date: 2025-12-24 @ 4:54 PM
Ignite Modification Date: 2026-01-06 @ 5:10 AM
Study NCT ID: NCT03409250
Status: COMPLETED
Last Update Posted: 2018-02-01
First Post: 2014-11-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia
Sponsor: Vista Klinik
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: MYOPIE-2011-04
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators